Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. (ADVM) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · ADVM · as of Jun 9, 2026
Key Statistics
Explore Adverum Biotechnologies, Inc. Data
advm stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 16 · Buy rate: 62.5%
The ADVM analyst consensus is Buy, based on ratings from 16 Wall Street analysts over the past 3 months. The average 12-month price target is $8.90, representing +104.13% upside from the current price of $4.36.
Competitors & Peers
advm competitorsADVM
ALXO
ARTV
ATYR
BMEA
DTILStock Performance
Full HistoryAbout Adverum Biotechnologies, Inc.
Adverum Biotechnologies, Inc. is a clinical-phase biotechnology firm primarily engaged in discovering and advancing gene therapies. The company's mission is to create innovative treatments for various…
what is adverum biotechnologies, inc. · advm stock overview · adverum biotechnologies, inc. company profile · who is adverum biotechnologies, inc. ceo · advm NASDAQ · adverum biotechnologies, inc. headquarters · adverum biotechnologies, inc. business segments
About Stock Overview & Key Data
Adverum Biotechnologies, Inc. (ADVM) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jul 31, 2014. As of the latest trading session, ADVM stock price is $4.36, with a market capitalization of $96.3M. The stock has returned -3.54% over the past 12 months and +0.00% year-to-date.
According to 16 Wall Street analysts, the consensus rating for Adverum Biotechnologies, Inc. stock is Buy, with an average 12-month price target of $8.90. In fiscal year 2024, Adverum Biotechnologies, Inc. reported revenue of $1.0M and net income of -$130.9M. For detailed data — including Adverum Biotechnologies, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Adverum Biotechnologies, Inc. (ADVM) stock price is $4.36. The stock is traded on NASDAQ under the ticker symbol ADVM. The 52-week range is $1.78 – $6.07.